Table 5 Univariate and multivariate analysis of factors associated with BOS change of temporal γPPA.
Independent variables | Univariate | Multivariate (IOP, MAP) | Multivariate (OPP) |
|---|---|---|---|
Time, month | 0.51 (1.1), 0.66 | ||
Sex, male versus female | 7.0 (2.4), 0.003* | ||
Hypertension | − 0.15 (3.6), 0.97 | ||
No. of baseline antiglaucoma eye drops | − 5.2 (2.5), 0.038* | ||
Age, year | − 0.24 (0.20), 0.24 | ||
Baseline axial length, mm | − 0.54 (1.6), 0.74 | ||
Baseline mean deviation, dB | 0.20 (0.31), 0.52 | ||
Baseline BOS, AU | − 0.67 (0.065), < 0.001* | − 0.59 (0.062), < 0.001* | − 0.61 (0.069), < 0.001* |
Baseline MT, AU | − 0.75 (0.54), 0.17 | ||
MT change, AU | 2.1 (0.64), 0.001* | 1.5 (0.56), 0.009* | 1.9 (0.73), 0.010* |
IOP change, mmHg | − 0.81 (0.18), < 0.001* | − 0.42 (0.14), 0.002* | |
MAP change, mmHg | 0.031 (0.11), 0.77 | ||
OPP change, mmHg | 0.28 (0.13), 0.035* | 0.26 (0.10), 0.011* | |
Pulse rate change, beats/min | − 0.064 (0.096), 0.50 | ||
Retinal thickness change, μm | 0.12 (0.098), 0.21 | ||
γPPA area, mm2 | − 3.8 (7.9), 0.63 | ||
Difference in LSFG measurement time | − 9.6 (9.4), 0.31 | − 3.0 (7.0), 0.67 | − 12.2 (8.9), 0.17 |